var data={"title":"Approach to the patient with macular skin lesions","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Approach to the patient with macular skin lesions</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/contributors\" class=\"contributor contributor_credentials\">Beth G Goldstein, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/contributors\" class=\"contributor contributor_credentials\">Adam O Goldstein, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/contributors\" class=\"contributor contributor_credentials\">Robert P Dellavalle, MD, PhD, MSPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jun 12, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Macules are nonpalpable lesions that vary in pigmentation from the surrounding skin. Macules are not raised or atrophic; clinicians must consider other salient features to assist in developing a reasonable differential diagnosis. Often, clinicians state that a dermatologic lesion is &quot;macular-papular,&quot; when in fact the lesion's morphology is papules and plaques, not macules. Definitions of dermatologic lesions can be found separately. (See <a href=\"topic.htm?path=approach-to-dermatologic-diagnosis\" class=\"medical medical_review\">&quot;Approach to dermatologic diagnosis&quot;</a>.) </p><p>Relatively few dermatologic disorders account for the majority of conditions presenting with only macules. Thus, the presence of these lesions can aid in forming an accurate diagnosis (<a href=\"image.htm?imageKey=PC%2F61066\" class=\"graphic graphic_table graphicRef61066 \">table 1</a>). One to two isolated macules in young children are often not pathologic; in adults, such lesions may occur frequently as a result of sun exposure [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/1,2\" class=\"abstract_t\">1,2</a>].</p><p>The presence of macules should raise the following questions:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>What is the distribution of the lesion?</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Is there erythema, hypo- or hyperpigmentation?</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Are there secondary characteristics such as scale or erythema?</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Is pruritus present?</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Is the patient taking any medications, such as prescription, over-the-counter, or herbal?</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Is there a photodistribution to the eruption?</p><p/><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">ERYTHEMATOUS MACULES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Erythematous macules are frequently caused by either viral exanthems (<a href=\"image.htm?imageKey=DERM%2F73806%7EID%2F57093%7EID%2F61263%7EPEDS%2F81967\" class=\"graphic graphic_picture graphicRef73806 graphicRef57093 graphicRef61263 graphicRef81967 \">picture 1A-D</a>) or drug eruptions (<a href=\"image.htm?imageKey=ALLRG%2F70062\" class=\"graphic graphic_picture graphicRef70062 \">picture 2</a>). Viral exanthems and drug eruptions tend to be diffuse with the majority of the eruption presenting as isolated, blanching erythematous macules on the trunk and proximal extremities. (See <a href=\"topic.htm?path=exanthematous-maculopapular-drug-eruption\" class=\"medical medical_review\">&quot;Exanthematous (maculopapular) drug eruption&quot;</a> and <a href=\"topic.htm?path=roseola-infantum-exanthem-subitum\" class=\"medical medical_review\">&quot;Roseola infantum (exanthem subitum)&quot;</a> and <a href=\"topic.htm?path=rubella\" class=\"medical medical_review\">&quot;Rubella&quot;</a> and <a href=\"topic.htm?path=measles-clinical-manifestations-diagnosis-treatment-and-prevention\" class=\"medical medical_review\">&quot;Measles: Clinical manifestations, diagnosis, treatment, and prevention&quot;</a>.)</p><p>Specific features may characterize certain exanthems, such as the reticulated erythematous eruption associated with erythema infectiosum (<a href=\"image.htm?imageKey=ID%2F75125%7EPEDS%2F89522%7EPEDS%2F71737\" class=\"graphic graphic_picture graphicRef75125 graphicRef89522 graphicRef71737 \">picture 3A-C</a>) or the diffuse erythema and perineal accentuation seen in Kawasaki's disease (<a href=\"image.htm?imageKey=DERM%2F91531%7EDERM%2F91532\" class=\"graphic graphic_picture graphicRef91531 graphicRef91532 \">picture 4A-B</a>). (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-parvovirus-b19-infection\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of parvovirus B19 infection&quot;</a> and <a href=\"topic.htm?path=kawasaki-disease-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Kawasaki disease: Clinical features and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">PHOTODISTRIBUTED MACULAR ERUPTIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Photodistributed macular eruptions may occur in a variety of skin conditions, including dermatomyositis (<a href=\"image.htm?imageKey=RHEUM%2F89101\" class=\"graphic graphic_picture graphicRef89101 \">picture 5</a>), systemic lupus erythematosus (<a href=\"image.htm?imageKey=DERM%2F75781\" class=\"graphic graphic_picture graphicRef75781 \">picture 6A</a>), porphyria cutanea tarda, drug reactions (<a href=\"image.htm?imageKey=DERM%2F86479\" class=\"graphic graphic_picture graphicRef86479 \">picture 7</a>), and polymorphous light eruptions. Photodistributed lesions often have accentuation on the face, the V of the neck, or the dorsa of the hands and forearms, sparing the infranasal and submental areas. Patients may present with lesions involving one or more sun-exposed areas. (See <a href=\"topic.htm?path=overview-of-cutaneous-photosensitivity-photobiology-patient-evaluation-and-photoprotection\" class=\"medical medical_review\">&quot;Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection&quot;</a> and <a href=\"topic.htm?path=photosensitivity-disorders-photodermatoses-clinical-manifestations-diagnosis-and-treatment\" class=\"medical medical_review\">&quot;Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Dermatomyositis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In dermatomyositis, the upper eyelids tend to develop a macular purplish hue and edema (<a href=\"image.htm?imageKey=RHEUM%2F73090\" class=\"graphic graphic_picture graphicRef73090 \">picture 8</a>). Confluent violaceous erythema may also be present on the arms, shoulders, upper back, or &quot;v&quot; area of the neck, and upper chest, and is often pruritic (<a href=\"image.htm?imageKey=RHEUM%2F51164\" class=\"graphic graphic_picture graphicRef51164 \">picture 9</a>). Areas of previous diffuse erythema may resolve with persistent poikiloderma (characterized by telangiectasia, mottled pigmentation, and some atrophy).</p><p>Mottled erythema and dilated superficial blood vessels, telangiectasia, are seen on the hands, particularly at the proximal nail fold (<a href=\"image.htm?imageKey=DERM%2F59545\" class=\"graphic graphic_picture graphicRef59545 \">picture 10</a>). Erythematous papules (Gottron's sign) may occur over the knuckles, knees, and elbows (<a href=\"image.htm?imageKey=RHEUM%2F70904%7ERHEUM%2F50909\" class=\"graphic graphic_picture graphicRef70904 graphicRef50909 \">picture 11A-B</a>). Patients may exhibit systemic symptoms such as fatigue, arthralgias, or other cutaneous findings. Skin findings can precede the onset of systemic disease or the disease may limit itself to the skin. (See <a href=\"topic.htm?path=clinical-manifestations-of-dermatomyositis-and-polymyositis-in-adults\" class=\"medical medical_review\">&quot;Clinical manifestations of dermatomyositis and polymyositis in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Systemic lupus erythematosus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Systemic lupus erythematosus tends to present with erythema in a malar distribution, the classic &quot;butterfly rash&quot; of the central face (<a href=\"image.htm?imageKey=DERM%2F75781%7EDERM%2F55875\" class=\"graphic graphic_picture graphicRef75781 graphicRef55875 \">picture 6A-B</a>), in addition to diffuse erythema in other sun-exposed locations [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/3\" class=\"abstract_t\">3</a>]. The additional presence of oral ulcerations may assist in making the diagnosis. (See <a href=\"topic.htm?path=overview-of-cutaneous-lupus-erythematosus\" class=\"medical medical_review\">&quot;Overview of cutaneous lupus erythematosus&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Drug-induced photosensitivity reactions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A history of taking a photosensitizing drug suggests the possibility of a photodrug eruption.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Phototoxic eruptions are the most common drug-induced photoeruption. The eruption is typically an exaggerated sunburn, often with blisters (<a href=\"image.htm?imageKey=DERM%2F86479\" class=\"graphic graphic_picture graphicRef86479 \">picture 7</a>). Nonsteroidal antiinflammatory drugs (NSAIDs), quinolones, tetracyclines, <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">amiodarone</a>, and the phenothiazines are the most frequent causes of phototoxicity [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/4\" class=\"abstract_t\">4</a>]. The eruption typically occurs with a higher cumulative dose of medication, in contrast to photoallergic drug eruptions, which can occur at any dose. Topical exposure to plant-derived substances may also cause a phototoxic reaction termed phytophotodermatitis (<a href=\"image.htm?imageKey=DERM%2F90428\" class=\"graphic graphic_picture graphicRef90428 \">picture 12</a>). (See <a href=\"topic.htm?path=photosensitivity-disorders-photodermatoses-clinical-manifestations-diagnosis-and-treatment#H22\" class=\"medical medical_review\">&quot;Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment&quot;, section on 'Phototoxicity'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Photoallergy is a lymphocyte-mediated reaction caused by exposure to ultraviolet A. The eruption is characterized by widespread eczema in the photodistribution: face, upper chest, and back of hands (<a href=\"image.htm?imageKey=DERM%2F63557\" class=\"graphic graphic_picture graphicRef63557 \">picture 13</a>). Most photoallergic reactions are caused by topical agents including biocides added to soaps (halogenated phenolic compounds) and fragrances such as musk ambrette and 6-methyl coumarin [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/5\" class=\"abstract_t\">5</a>]. Systemic photoallergens such as the phenothiazines, <a href=\"topic.htm?path=chlorpromazine-drug-information\" class=\"drug drug_general\">chlorpromazine</a>, sulfa products, and NSAIDs can produce photoallergic reactions, although most of their photosensitive reactions are phototoxic [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/5\" class=\"abstract_t\">5</a>]. (See <a href=\"topic.htm?path=photosensitivity-disorders-photodermatoses-clinical-manifestations-diagnosis-and-treatment#H25\" class=\"medical medical_review\">&quot;Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment&quot;, section on 'Photoallergy'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Porphyria cutanea tarda</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Porphyria cutanea tarda may present as diffuse erythema in a photodistributed pattern. Typically, there are also vesicles or bullae, scarring, and hypertrichosis (<a href=\"image.htm?imageKey=GAST%2F74528%7EDERM%2F78547\" class=\"graphic graphic_picture graphicRef74528 graphicRef78547 \">picture 14A-B</a>). (See <a href=\"topic.htm?path=porphyria-cutanea-tarda-and-hepatoerythropoietic-porphyria-pathogenesis-clinical-manifestations-and-diagnosis#H2866233\" class=\"medical medical_review\">&quot;Porphyria cutanea tarda and hepatoerythropoietic porphyria: Pathogenesis, clinical manifestations, and diagnosis&quot;, section on 'Blistering skin lesions and other cutaneous manifestations'</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Polymorphous light eruption</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Polymorphous light eruption is a diagnosis of exclusion. Once all of the above conditions have been considered, a light-induced, pruritic eruption, particularly occurring with the first intense sun exposure of the year, may be consistent with this diagnosis. Polymorphous light eruption can present simply as diffuse erythema. Look for accentuation of the eruption on the arms and thighs; the face may be spared entirely or only slightly involved (<a href=\"image.htm?imageKey=DERM%2F51455\" class=\"graphic graphic_picture graphicRef51455 \">picture 15</a>). (See <a href=\"topic.htm?path=polymorphous-light-eruption\" class=\"medical medical_review\">&quot;Polymorphous light eruption&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">HYPOPIGMENTED MACULES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypopigmented macules are distinguished from depigmented macules by retention of some pigment.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Vitiligo</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vitiligo presents primarily as an acquired, isolated, or diffuse depigmentation (<a href=\"image.htm?imageKey=PC%2F72369\" class=\"graphic graphic_picture graphicRef72369 \">picture 16</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/6\" class=\"abstract_t\">6</a>]. Hypopigmented areas may also occur during the process of developing or resolving vitiligo. Vitiligo is an autoimmune process against melanocytes; the etiology is unknown. (See <a href=\"topic.htm?path=vitiligo-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Vitiligo: Pathogenesis, clinical features, and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Tinea versicolor</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypopigmentation, particularly on the trunk and proximal extremities, in a mottled distribution, is suggestive of tinea versicolor. Lesions may also be light brown or salmon colored (<a href=\"image.htm?imageKey=PC%2F59533%7EPC%2F78860\" class=\"graphic graphic_picture graphicRef59533 graphicRef78860 \">picture 17A-B</a>). Tinea versicolor may seem to be photoaccentuated as the areas involved fail to tan and become more prominent with sun exposure. This disorder is seen in young adults and those living in humid climates. The diagnosis is confirmed with a positive KOH prep for yeast and hyphae. Erythrasma, a bacterial infection, is a similar appearing eruption that is <span class=\"nowrap\">pink/brown,</span> slightly scaly, and occurs in the inguinal region (<a href=\"image.htm?imageKey=DERM%2F51713\" class=\"graphic graphic_picture graphicRef51713 \">picture 18</a>). (See <a href=\"topic.htm?path=tinea-versicolor-pityriasis-versicolor\" class=\"medical medical_review\">&quot;Tinea versicolor (Pityriasis versicolor)&quot;</a> and <a href=\"topic.htm?path=erythrasma\" class=\"medical medical_review\">&quot;Erythrasma&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Halo nevus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A halo nevus is a depigmented macule that presents in conjunction with a pre-existing pigmented lesion. A halo nevus is caused by a T-cell mediated immune reaction with melanocytic nevus cells, ultimately causing the loss of all pigmentation of and around a nevus (<a href=\"image.htm?imageKey=DERM%2F57744\" class=\"graphic graphic_picture graphicRef57744 \">picture 19</a>). Halo nevi are typically a benign process, but occasionally may be associated with the presence of an atypical melanocytic lesion. (See <a href=\"topic.htm?path=acquired-melanocytic-nevi-moles#H18\" class=\"medical medical_review\">&quot;Acquired melanocytic nevi (moles)&quot;, section on 'Halo nevi'</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Pityriasis alba</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pityriasis alba occurs predominantly in children aged 3 to 16 years of age [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/7\" class=\"abstract_t\">7</a>]. It is characterized by patches of hypopigmentation, usually distributed on the face, neck, upper trunk, and proximal extremities (<a href=\"image.htm?imageKey=DERM%2F60866%7EDERM%2F73576\" class=\"graphic graphic_picture graphicRef60866 graphicRef73576 \">picture 20A-B</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/8,9\" class=\"abstract_t\">8,9</a>]. The lesions range from 0.5 to 5 cm in diameter, with well-defined but somewhat irregular borders, and fine scale. They usually are asymptomatic but may be pruritic. Patients often present after sun exposure when the contrast between affected and nonaffected areas is accentuated by tanning [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/9\" class=\"abstract_t\">9</a>].</p><p>Pityriasis alba is thought to represent a nonspecific dermatitis with residual postinflammatory hypopigmentation [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/9-11\" class=\"abstract_t\">9-11</a>]. It is associated with atopy, sun exposure, and frequency of bathing [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/10\" class=\"abstract_t\">10</a>].</p><p>The affected sites and surrounding areas should be protected from sun exposure. Mild topical glucocorticoids or calcineurin inhibitors and emollients decrease dryness and scale and may accelerate repigmentation, which typically takes months to years [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/8,9,12\" class=\"abstract_t\">8,9,12</a>]. Moisturization during the winter months may prevent recurrence in subsequent summers. (See <a href=\"topic.htm?path=acquired-hypopigmentation-disorders-other-than-vitiligo#H2110840350\" class=\"medical medical_review\">&quot;Acquired hypopigmentation disorders other than vitiligo&quot;, section on 'Pityriasis alba'</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Others</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Depigmented areas at birth can also represent ash leaf spots seen in tuberous sclerosis (<a href=\"image.htm?imageKey=PEDS%2F91042%7EPEDS%2F61601\" class=\"graphic graphic_picture graphicRef91042 graphicRef61601 \">picture 21A-B</a>), nevus depigmentosus (achromic nevus) (<a href=\"image.htm?imageKey=DERM%2F108149\" class=\"graphic graphic_picture graphicRef108149 \">picture 22</a>), or nevus anemicus (<a href=\"image.htm?imageKey=DERM%2F108038\" class=\"graphic graphic_picture graphicRef108038 \">picture 23</a>), among others [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/13,14\" class=\"abstract_t\">13,14</a>]. Some systemic conditions, such as cutaneous T cell lymphoma and leprosy can present with hypopigmented lesions on the trunk and extremities [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/15,16\" class=\"abstract_t\">15,16</a>]. Sarcoidosis can also present as areas of splotchy hypopigmentation, typically on the anterior lower extremities. Systemic and pulmonary findings of sarcoidosis may appear simultaneously. Rarely, cutaneous T cell lymphoma (mycosis fungoides) can present as hypopigmented macules. (See <a href=\"topic.htm?path=acquired-hypopigmentation-disorders-other-than-vitiligo\" class=\"medical medical_review\">&quot;Acquired hypopigmentation disorders other than vitiligo&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">HYPERPIGMENTED MACULES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hyperpigmented macules may signify several different disease processes.</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Postinflammatory hyperpigmentation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Diffuse hyperpigmentation often accompanies postinflammatory hyperpigmentation, which can occur anywhere after an inciting eruption has resolved [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/17\" class=\"abstract_t\">17</a>]. Postinflammatory hyperpigmentation is particularly common in darker skin types when inflammatory conditions such as acne, psoriasis, or eczema are resolving (<a href=\"image.htm?imageKey=DERM%2F78119\" class=\"graphic graphic_picture graphicRef78119 \">picture 24</a>). (See <a href=\"topic.htm?path=postinflammatory-hyperpigmentation\" class=\"medical medical_review\">&quot;Postinflammatory hyperpigmentation&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Melasma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Melasma occurs as splotchy hyperpigmented macules, typically in a photodistributed pattern, often with accentuation on the upper lip (<a href=\"image.htm?imageKey=DERM%2F64109%7EDERM%2F52220\" class=\"graphic graphic_picture graphicRef64109 graphicRef52220 \">picture 25A-B</a>). Melasma tends to occur most commonly in pregnancy and in conjunction with exogenous hormones, but may also occur in males. (See <a href=\"topic.htm?path=melasma\" class=\"medical medical_review\">&quot;Melasma&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Solar purpura (senile purpura)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Solar purpura (also called actinic purpura, or Bateman purpura) is a common form of non-inflammatory purpura. It presents as ecchymotic lesions predominantly on the sun-damaged skin of the forearms and dorsa of the hands of older adult individuals (<a href=\"image.htm?imageKey=DERM%2F54977\" class=\"graphic graphic_picture graphicRef54977 \">picture 26</a>). These lesions result from rupture of superficial blood vessels with subsequent extravasation of blood in the dermis following a minor trauma. The incidence and severity of solar purpura are increased in individuals taking anticoagulants or corticosteroids. The ecchymoses may persist for several weeks and resolve spontaneously without undergoing the usual sequential color changes of a normal bruise. Residual hyperpigmentation can be observed.</p><p class=\"headingAnchor\" id=\"H1614701\"><span class=\"h2\">Erythema ab igne</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Erythema ab igne is a reticular erythematous pigmented dermatosis resulting from repeated exposures to moderate heat or infrared radiation. Once common among people who sat near open fires or stoves, it is infrequently seen after the introduction of central heating. However, it is still seen in relation to occupational exposure to heat sources (foundry workers, bakers), use of hot water bottles, heating pads or blankets (<a href=\"image.htm?imageKey=DERM%2F72011\" class=\"graphic graphic_picture graphicRef72011 \">picture 27</a>), heated car seats, and among laptop users who hold the computer on their thighs [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/18-20\" class=\"abstract_t\">18-20</a>]. It can occur at any site, more often in an asymmetrical distribution, and is usually asymptomatic. The early skin changes of erythema ab igne usually clear spontaneously in several weeks to months, after the removal of the heat source from the skin. However, longstanding lesions may be associated with permanent hyperpigmentation (<a href=\"image.htm?imageKey=DERM%2F52027\" class=\"graphic graphic_picture graphicRef52027 \">picture 28</a>). (See <a href=\"topic.htm?path=acquired-hyperpigmentation-disorders#H777911091\" class=\"medical medical_review\">&quot;Acquired hyperpigmentation disorders&quot;, section on 'Erythema ab igne'</a>.)</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Solar lentigo</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Solar lentigo, most commonly known as liver spots or &quot;old age'' spots, is a proliferation of normal melanocytes secondary to chronic solar damage. These lesions occur most commonly in whites with fair complexion who have a history of chronic sun exposure. Hyperpigmentation may vary from light to dark brown, but is uniform within an individual lesion. The diagnosis is based upon the clinical appearance of flat, oval, evenly pigmented macules in (<a href=\"image.htm?imageKey=DERM%2F86484%7EDERM%2F61452\" class=\"graphic graphic_picture graphicRef86484 graphicRef61452 \">picture 29A-B</a>) areas of chronic sun exposure, particularly the face, dorsa of the hands, shoulders, and back. (See <a href=\"topic.htm?path=acquired-hyperpigmentation-disorders#H1107851782\" class=\"medical medical_review\">&quot;Acquired hyperpigmentation disorders&quot;, section on 'Solar lentigines'</a>.)</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Schamberg's disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Schamberg's disease, also called Schamberg's purpura is a type of pigmented purpuric dermatosis characterized by brownish discoloration of the skin, particularly of the lower extremities and ankle area (<a href=\"image.htm?imageKey=DERM%2F67127\" class=\"graphic graphic_picture graphicRef67127 \">picture 30</a>) [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/21\" class=\"abstract_t\">21</a>]. It is caused by capillary leakage of blood and subsequent breakdown, resulting in hemosiderin staining. (See <a href=\"topic.htm?path=pigmented-purpuric-dermatoses-capillaritis#H603960\" class=\"medical medical_review\">&quot;Pigmented purpuric dermatoses (capillaritis)&quot;, section on 'Schamberg's disease (progressive pigmentary purpura)'</a>.)</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Ochronosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>&quot;Ochronosis&quot; is a term used to describe pigment deposition that occurs in the connective tissues of patients with alkaptonuria, an autosomal recessive disorder that results from a deficiency of homogentisic acid oxidase (<a href=\"image.htm?imageKey=PEDS%2F60616\" class=\"graphic graphic_picture graphicRef60616 \">picture 31</a>). Brown or blue-gray discoloration of the skin may be seen on the axillary and inguinal areas, face, palms, or soles. In addition, blue-black discoloration can be apparent on skin overlying cartilage in which the pigment is deposited, such as the ears. The sclerae are also typically involved. (See <a href=\"topic.htm?path=disorders-of-tyrosine-metabolism#H19\" class=\"medical medical_review\">&quot;Disorders of tyrosine metabolism&quot;, section on 'Alkaptonuria'</a>.)</p><p>The term &quot;exogenous ochronosis&quot; is used to refer to the occurrence of localized blue-gray discoloration of the skin associated with the use of topical <a href=\"topic.htm?path=hydroquinone-drug-information\" class=\"drug drug_general\">hydroquinone</a>. (See <a href=\"topic.htm?path=topical-skin-lightening-agents-complications-associated-with-misuse#H3905541245\" class=\"medical medical_review\">&quot;Topical skin-lightening agents: Complications associated with misuse&quot;, section on 'Exogenous ochronosis'</a>.)</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Fixed drug eruption</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A fixed drug eruption is characterized acutely by erythematous and edematous plaques with a grayish center or frank bullae, and chronically by a dark postinflammatory pigmentation (<a href=\"image.htm?imageKey=DERM%2F73678\" class=\"graphic graphic_picture graphicRef73678 \">picture 32</a>). Favored sites include the mouth (lips and tongue), genitalia, face, and acral areas [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/4\" class=\"abstract_t\">4</a>]. The defining features of this eruption include the postinflammatory hyperpigmentation and the recurrence of lesions at exactly the same site with drug reexposure [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/4\" class=\"abstract_t\">4</a>]. The drugs commonly involved include phenolphthalein (laxatives), tetracyclines, barbiturates, sulfonamides, nonsteroidal antiinflammatory drugs (NSAIDs), and salicylates [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/2\" class=\"abstract_t\">2</a>]. (See <a href=\"topic.htm?path=fixed-drug-eruption\" class=\"medical medical_review\">&quot;Fixed drug eruption&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h2\">Melanoma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A changing, pigmented macule should raise suspicion for melanoma [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/22\" class=\"abstract_t\">22</a>]. Changes suggestive of a melanoma include asymmetry, change in size (particularly, but not necessarily, larger than 6 mm), irregular or notched borders, change in color, or change in sensation (<a href=\"image.htm?imageKey=PC%2F78826\" class=\"graphic graphic_picture graphicRef78826 \">picture 33</a>). (See <a href=\"topic.htm?path=melanoma-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Melanoma: Clinical features and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h2\">Others</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of isolated, stable hyperpigmented macules also includes sun-induced lentigines, ephelides (freckles), caf&eacute;-au-lait macules, bluish-black lesions (Mongolian spots), or nevi. (See <a href=\"topic.htm?path=acquired-hyperpigmentation-disorders\" class=\"medical medical_review\">&quot;Acquired hyperpigmentation disorders&quot;</a>.)</p><p>Minocycline-induced hyperpigmentation tends to be isolated, hyperpigmented blue-black macules predominantly located in scars [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/23\" class=\"abstract_t\">23</a>]. Isolated or diffuse pinkish brown lesions that urticate upon pressure, rubbing, or heat are suggestive of mastocytomas or <span class=\"nowrap\">mastocytosis/urticaria</span> pigmentosa [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/24,25\" class=\"abstract_t\">24,25</a>]. (See <a href=\"topic.htm?path=mastocytosis-cutaneous-and-systemic-epidemiology-pathogenesis-and-clinical-manifestations\" class=\"medical medical_review\">&quot;Mastocytosis (cutaneous and systemic): Epidemiology, pathogenesis, and clinical manifestations&quot;</a>.) </p><p>Irregular whorls of hyperpigmentation may occur during treatment with <a href=\"topic.htm?path=bleomycin-drug-information\" class=\"drug drug_general\">bleomycin</a> and after ingestion of shiitake mushrooms [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/26,27\" class=\"abstract_t\">26,27</a>]. (See <a href=\"topic.htm?path=cutaneous-side-effects-of-conventional-chemotherapy-agents#H8\" class=\"medical medical_review\">&quot;Cutaneous side effects of conventional chemotherapy agents&quot;, section on 'Serpentine, flagellate, and reticular hyperpigmentation'</a> and <a href=\"topic.htm?path=acquired-hyperpigmentation-disorders#H42492127\" class=\"medical medical_review\">&quot;Acquired hyperpigmentation disorders&quot;, section on 'Drug-induced linear hyperpigmentation'</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topic (see <a href=\"topic.htm?path=melasma-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Melasma (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H25\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Macules are flat skin lesions that may occur in a variety of skin disorders. Characteristics such as lesion distribution, color, and associated signs or symptoms are useful for identifying the correct diagnosis. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Erythematous macules are frequently caused by either viral exanthems (<a href=\"image.htm?imageKey=DERM%2F73806%7EID%2F57093%7EID%2F61263%7EPEDS%2F81967\" class=\"graphic graphic_picture graphicRef73806 graphicRef57093 graphicRef61263 graphicRef81967 \">picture 1A-D</a>) or drug eruptions (<a href=\"image.htm?imageKey=ALLRG%2F70062\" class=\"graphic graphic_picture graphicRef70062 \">picture 2</a>). (See <a href=\"#H2\" class=\"local\">'Erythematous macules'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Photosensitive disorders may present with macular lesions in areas exposed to sunlight. Examples of autoimmune disorders that can exhibit these findings include dermatomyositis (<a href=\"image.htm?imageKey=RHEUM%2F89101\" class=\"graphic graphic_picture graphicRef89101 \">picture 5</a>) and systemic lupus erythematosus (<a href=\"image.htm?imageKey=DERM%2F75781\" class=\"graphic graphic_picture graphicRef75781 \">picture 6A</a>). Medications can also induce photodistributed macular skin reactions (<a href=\"image.htm?imageKey=DERM%2F63557\" class=\"graphic graphic_picture graphicRef63557 \">picture 13</a>). Phototoxic drug eruptions resemble an exaggerated sunburn and may be accompanied by blisters (<a href=\"image.htm?imageKey=DERM%2F86479\" class=\"graphic graphic_picture graphicRef86479 \">picture 7</a>). (See <a href=\"#H3\" class=\"local\">'Photodistributed macular eruptions'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pigmentation is a feature that can assist in the diagnosis of macular skin disorders. Hypopigmented macules may range from lesions that are slightly lighter in color than unaffected skin to completely depigmented areas of skin, as are seen in vitiligo or halo nevi. Hyperpigmented macules may occur as a feature of a primary skin disorder or as a consequence of a preceding inflammatory process (postinflammatory hyperpigmentation). (See <a href=\"#H9\" class=\"local\">'Hypopigmented macules'</a> above and <a href=\"#H15\" class=\"local\">'Hyperpigmented macules'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/1\" class=\"nounderline abstract_t\">Vanderhooft SL, Francis JS, Pagon RA, et al. Prevalence of hypopigmented macules in a healthy population. J Pediatr 1996; 129:355.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/2\" class=\"nounderline abstract_t\">Pagnoni A, Kligman AM, Sadiq I, Stoudemayer T. Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin. Acta Derm Venereol 1999; 79:305.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/3\" class=\"nounderline abstract_t\">Drenkard C, Villa AR, Reyes E, et al. Vasculitis in systemic lupus erythematosus. Lupus 1997; 6:235.</a></li><li class=\"breakAll\">Stern RS, Shear NH. Cutaneous reactions to drugs and biological modifiers. In: Cutaneous Medicine and Surgery, Arndt KA, LeBoit PE, Robinson JK, Wintroub BU (Eds), W.B. Saunders, Philadelphia 1996. Vol 1, p.412.</li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/5\" class=\"nounderline abstract_t\">Gonz&aacute;lez E, Gonz&aacute;lez S. Drug photosensitivity, idiopathic photodermatoses, and sunscreens. J Am Acad Dermatol 1996; 35:871.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/6\" class=\"nounderline abstract_t\">Jimbow K. Vitiligo. Therapeutic advances. Dermatol Clin 1998; 16:399.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/7\" class=\"nounderline abstract_t\">Leung AK, Feingold M. Pityriasis alba. Am J Dis Child 1986; 140:379.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/8\" class=\"nounderline abstract_t\">Galan EB, Janniger CK. Pityriasis alba. Cutis 1998; 61:11.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/9\" class=\"nounderline abstract_t\">Lin RL, Janniger CK. Pityriasis alba. Cutis 2005; 76:21.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/10\" class=\"nounderline abstract_t\">Blessmann Weber M, Sponchiado de Avila LG, Albaneze R, et al. Pityriasis alba: a study of pathogenic factors. J Eur Acad Dermatol Venereol 2002; 16:463.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/11\" class=\"nounderline abstract_t\">Urano-Suehisa S, Tagami H. Functional and morphological analysis of the horny layer of pityriasis alba. Acta Derm Venereol 1985; 65:164.</a></li><li class=\"breakAll\">Eczematous eruptions in childhood. In: Hurwitz Clinical Pediatric Dermatology: A Textbook of Skin Disorders of Childhood and Adolescence, 3rd ed, Paller AS, Mancini AJ (Eds), WB Saunders, Philadelphia 2006. p.49.</li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/13\" class=\"nounderline abstract_t\">J&oacute;&#378;wiak S, Schwartz RA, Janniger CK, et al. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol 1998; 37:911.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/14\" class=\"nounderline abstract_t\">Miura Y, Tajima S, Ishibashi A, Hata Y. Multiple anemic macules on the arms: a variant form of nevus anemicus? Dermatology 2000; 201:180.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/15\" class=\"nounderline abstract_t\">Choe YB, Park KC, Cho KH. A case of hypopigmented mycosis fungoides. J Dermatol 2000; 27:543.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/16\" class=\"nounderline abstract_t\">Sarkar R, Kaur I, Das A, Sharma VK. Macular lesions in leprosy: a clinical, bacteriological and histopathological study. J Dermatol 1999; 26:569.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/17\" class=\"nounderline abstract_t\">Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol Clin 2000; 18:91.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/18\" class=\"nounderline abstract_t\">Beleznay K, Humphrey S, Au S. Erythema ab igne. CMAJ 2010; 182:E228.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/19\" class=\"nounderline abstract_t\">Arnold AW, Itin PH. Laptop computer-induced erythema ab igne in a child and review of the literature. Pediatrics 2010; 126:e1227.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/20\" class=\"nounderline abstract_t\">Adams BB. Heated car seat-induced erythema ab igne. Arch Dermatol 2012; 148:265.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/21\" class=\"nounderline abstract_t\">Ratnam KV, Su WP, Peters MS. Purpura simplex (inflammatory purpura without vasculitis): a clinicopathologic study of 174 cases. J Am Acad Dermatol 1991; 25:642.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/22\" class=\"nounderline abstract_t\">Rocamora V, Puig L, Roman&iacute; J, de Moragas JM. Amelanotic lentigo maligna melanoma: report of a case and review of the literature. Cutis 1999; 64:53.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/23\" class=\"nounderline abstract_t\">Geria AN, Tajirian AL, Kihiczak G, Schwartz RA. Minocycline-induced skin pigmentation: an update. Acta Dermatovenerol Croat 2009; 17:123.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/24\" class=\"nounderline abstract_t\">Alto WA, Clarcq L. Cutaneous and systemic manifestations of mastocytosis. Am Fam Physician 1999; 59:3047.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/25\" class=\"nounderline abstract_t\">Pollack CV Jr, Pender ES. Recognizing an index case of type 1 neurofibromatosis. Am Fam Physician 1992; 45:623.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/26\" class=\"nounderline abstract_t\">Wang AS, Barr KL, Jagdeo J. Shiitake mushroom-induced flagellate erythema: A striking case and review of the literature. Dermatol Online J 2013; 19:5.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-macular-skin-lesions/abstract/27\" class=\"nounderline abstract_t\">Todkill D, Taibjee S, Borg A, Gee BC. Flagellate erythema due to bleomycin. Br J Haematol 2008; 142:857.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 1732 Version 19.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H25\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">ERYTHEMATOUS MACULES</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">PHOTODISTRIBUTED MACULAR ERUPTIONS</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Dermatomyositis</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Systemic lupus erythematosus</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Drug-induced photosensitivity reactions</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Porphyria cutanea tarda</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Polymorphous light eruption</a></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">HYPOPIGMENTED MACULES</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">Vitiligo</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Tinea versicolor</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Halo nevus</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Pityriasis alba</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">Others</a></li></ul></li><li><a href=\"#H15\" id=\"outline-link-H15\">HYPERPIGMENTED MACULES</a><ul><li><a href=\"#H16\" id=\"outline-link-H16\">Postinflammatory hyperpigmentation</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">Melasma</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">Solar purpura (senile purpura)</a></li><li><a href=\"#H1614701\" id=\"outline-link-H1614701\">Erythema ab igne</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">Solar lentigo</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">Schamberg's disease</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">Ochronosis</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">Fixed drug eruption</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">Melanoma</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">Others</a></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H100411145\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H25\" id=\"outline-link-H25\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/1732|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/73806\" class=\"graphic graphic_picture\">- Measles facial eruption</a></li><li><a href=\"image.htm?imageKey=ID/57093\" class=\"graphic graphic_picture\">- Truncal rash in measles</a></li><li><a href=\"image.htm?imageKey=ID/61263\" class=\"graphic graphic_picture\">- Rubella rash</a></li><li><a href=\"image.htm?imageKey=PEDS/81967\" class=\"graphic graphic_picture\">- Roseola rash</a></li><li><a href=\"image.htm?imageKey=ALLRG/70062\" class=\"graphic graphic_picture\">- Exanthematous (morbilliform) drug eruption</a></li><li><a href=\"image.htm?imageKey=ID/75125\" class=\"graphic graphic_picture\">- Rash in erythema infectiosum</a></li><li><a href=\"image.htm?imageKey=PEDS/89522\" class=\"graphic graphic_picture\">- Slapped cheek rash 2</a></li><li><a href=\"image.htm?imageKey=PEDS/71737\" class=\"graphic graphic_picture\">- Slapped cheek rash</a></li><li><a href=\"image.htm?imageKey=DERM/91531\" class=\"graphic graphic_picture\">- Kawasaki rash</a></li><li><a href=\"image.htm?imageKey=DERM/91532\" class=\"graphic graphic_picture\">- Kawasaki perineal erythema</a></li><li><a href=\"image.htm?imageKey=RHEUM/89101\" class=\"graphic graphic_picture\">- Heliotrope eruption in dermatomyositis</a></li><li><a href=\"image.htm?imageKey=DERM/75781\" class=\"graphic graphic_picture\">- Acute cutaneous lupus erythematosus - malar</a></li><li><a href=\"image.htm?imageKey=DERM/86479\" class=\"graphic graphic_picture\">- Phototoxic eruption</a></li><li><a href=\"image.htm?imageKey=RHEUM/73090\" class=\"graphic graphic_picture\">- Heliotrope eruption in DM</a></li><li><a href=\"image.htm?imageKey=RHEUM/51164\" class=\"graphic graphic_picture\">- Shawl sign</a></li><li><a href=\"image.htm?imageKey=DERM/59545\" class=\"graphic graphic_picture\">- Dermatomyositis dilated capillary loops</a></li><li><a href=\"image.htm?imageKey=RHEUM/70904\" class=\"graphic graphic_picture\">- Gottrons sign in DM I</a></li><li><a href=\"image.htm?imageKey=RHEUM/50909\" class=\"graphic graphic_picture\">- Gottrons sign in DM II</a></li><li><a href=\"image.htm?imageKey=DERM/55875\" class=\"graphic graphic_picture\">- Acute cutaneous lupus erythematosus - malar eruption</a></li><li><a href=\"image.htm?imageKey=DERM/90428\" class=\"graphic graphic_picture\">- Phytophotodermatitis leg</a></li><li><a href=\"image.htm?imageKey=DERM/63557\" class=\"graphic graphic_picture\">- Photoallergic eruption 2</a></li><li><a href=\"image.htm?imageKey=GAST/74528\" class=\"graphic graphic_picture\">- Porphyria cutanea tarda</a></li><li><a href=\"image.htm?imageKey=DERM/78547\" class=\"graphic graphic_picture\">- Porphyria cutanea tarda 2</a></li><li><a href=\"image.htm?imageKey=DERM/51455\" class=\"graphic graphic_picture\">- Polymorphous light eruption on face</a></li><li><a href=\"image.htm?imageKey=PC/72369\" class=\"graphic graphic_picture\">- Vitiligo segmental</a></li><li><a href=\"image.htm?imageKey=PC/59533\" class=\"graphic graphic_picture\">- Tinea versicolor arm</a></li><li><a href=\"image.htm?imageKey=PC/78860\" class=\"graphic graphic_picture\">- Tinea versicolor chest</a></li><li><a href=\"image.htm?imageKey=DERM/51713\" class=\"graphic graphic_picture\">- Intertriginous erythrasma</a></li><li><a href=\"image.htm?imageKey=DERM/57744\" class=\"graphic graphic_picture\">- Halo nevus 2</a></li><li><a href=\"image.htm?imageKey=DERM/60866\" class=\"graphic graphic_picture\">- Pityriasis alba 1</a></li><li><a href=\"image.htm?imageKey=DERM/73576\" class=\"graphic graphic_picture\">- Pityriasis alba 2</a></li><li><a href=\"image.htm?imageKey=PEDS/91042\" class=\"graphic graphic_picture\">- Child with TSC and hypomelanotic macules</a></li><li><a href=\"image.htm?imageKey=PEDS/61601\" class=\"graphic graphic_picture\">- TSC hypomelanotic macule</a></li><li><a href=\"image.htm?imageKey=DERM/108149\" class=\"graphic graphic_picture\">- Nevus depigmentosus</a></li><li><a href=\"image.htm?imageKey=DERM/108038\" class=\"graphic graphic_picture\">- Nevus anemicus face</a></li><li><a href=\"image.htm?imageKey=DERM/78119\" class=\"graphic graphic_picture\">- Acne hyperpigmentation</a></li><li><a href=\"image.htm?imageKey=DERM/64109\" class=\"graphic graphic_picture\">- Melasma cheek</a></li><li><a href=\"image.htm?imageKey=DERM/52220\" class=\"graphic graphic_picture\">- Melasma lip</a></li><li><a href=\"image.htm?imageKey=DERM/54977\" class=\"graphic graphic_picture\">- Actinic purpura</a></li><li><a href=\"image.htm?imageKey=DERM/72011\" class=\"graphic graphic_picture\">- Erythema ab igne</a></li><li><a href=\"image.htm?imageKey=DERM/52027\" class=\"graphic graphic_picture\">- Erythema ab igne hyperpigmentation</a></li><li><a href=\"image.htm?imageKey=DERM/86484\" class=\"graphic graphic_picture\">- Solar lentigo back</a></li><li><a href=\"image.htm?imageKey=DERM/61452\" class=\"graphic graphic_picture\">- Solar lentigo hand 2</a></li><li><a href=\"image.htm?imageKey=DERM/67127\" class=\"graphic graphic_picture\">- Schambergs disease</a></li><li><a href=\"image.htm?imageKey=PEDS/60616\" class=\"graphic graphic_picture\">- Ochronotic pigmentation 2</a></li><li><a href=\"image.htm?imageKey=DERM/73678\" class=\"graphic graphic_picture\">- Fixed drug hyperpigment</a></li><li><a href=\"image.htm?imageKey=PC/78826\" class=\"graphic graphic_picture\">- Acral lentiginous melanoma</a></li></ul></li><li><div id=\"DERM/1732|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PC/61066\" class=\"graphic graphic_table\">- Macules</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acquired-hyperpigmentation-disorders\" class=\"medical medical_review\">Acquired hyperpigmentation disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acquired-hypopigmentation-disorders-other-than-vitiligo\" class=\"medical medical_review\">Acquired hypopigmentation disorders other than vitiligo</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acquired-melanocytic-nevi-moles\" class=\"medical medical_review\">Acquired melanocytic nevi (moles)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-dermatologic-diagnosis\" class=\"medical medical_review\">Approach to dermatologic diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-parvovirus-b19-infection\" class=\"medical medical_review\">Clinical manifestations and diagnosis of parvovirus B19 infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-dermatomyositis-and-polymyositis-in-adults\" class=\"medical medical_review\">Clinical manifestations of dermatomyositis and polymyositis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cutaneous-side-effects-of-conventional-chemotherapy-agents\" class=\"medical medical_review\">Cutaneous side effects of conventional chemotherapy agents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=disorders-of-tyrosine-metabolism\" class=\"medical medical_review\">Disorders of tyrosine metabolism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=erythrasma\" class=\"medical medical_review\">Erythrasma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=exanthematous-maculopapular-drug-eruption\" class=\"medical medical_review\">Exanthematous (maculopapular) drug eruption</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=fixed-drug-eruption\" class=\"medical medical_review\">Fixed drug eruption</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=kawasaki-disease-clinical-features-and-diagnosis\" class=\"medical medical_review\">Kawasaki disease: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mastocytosis-cutaneous-and-systemic-epidemiology-pathogenesis-and-clinical-manifestations\" class=\"medical medical_review\">Mastocytosis (cutaneous and systemic): Epidemiology, pathogenesis, and clinical manifestations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=measles-clinical-manifestations-diagnosis-treatment-and-prevention\" class=\"medical medical_review\">Measles: Clinical manifestations, diagnosis, treatment, and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=melanoma-clinical-features-and-diagnosis\" class=\"medical medical_review\">Melanoma: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=melasma\" class=\"medical medical_review\">Melasma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-cutaneous-lupus-erythematosus\" class=\"medical medical_review\">Overview of cutaneous lupus erythematosus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-cutaneous-photosensitivity-photobiology-patient-evaluation-and-photoprotection\" class=\"medical medical_review\">Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=melasma-the-basics\" class=\"medical medical_basics\">Patient education: Melasma (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=photosensitivity-disorders-photodermatoses-clinical-manifestations-diagnosis-and-treatment\" class=\"medical medical_review\">Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pigmented-purpuric-dermatoses-capillaritis\" class=\"medical medical_review\">Pigmented purpuric dermatoses (capillaritis)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=polymorphous-light-eruption\" class=\"medical medical_review\">Polymorphous light eruption</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=porphyria-cutanea-tarda-and-hepatoerythropoietic-porphyria-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Porphyria cutanea tarda and hepatoerythropoietic porphyria: Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=postinflammatory-hyperpigmentation\" class=\"medical medical_review\">Postinflammatory hyperpigmentation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=roseola-infantum-exanthem-subitum\" class=\"medical medical_review\">Roseola infantum (exanthem subitum)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rubella\" class=\"medical medical_review\">Rubella</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tinea-versicolor-pityriasis-versicolor\" class=\"medical medical_review\">Tinea versicolor (Pityriasis versicolor)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=topical-skin-lightening-agents-complications-associated-with-misuse\" class=\"medical medical_review\">Topical skin-lightening agents: Complications associated with misuse</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vitiligo-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">Vitiligo: Pathogenesis, clinical features, and diagnosis</a></li></ul></div></div>","javascript":null}